ReviewEuropean journal of nuclear medicine and molecular imaging2024

Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?

Janke Kleynhans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.